The DOI matches its Crossref record; 288 of the 295 references it cites were found in a registry or an index.
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
Open accessAbstract
Melanoma is a highly aggressive cancer with the poorest prognosis, representing the deadliest form of skin cancer. Activating mutations in BRAF are the most frequent genetic alterations, present in approximately 50% of all melanoma cases. The use of specific inhibitors towards mutant BRAF variants and MEK, a downstream signaling target of BRAF in the MAPK pathway, has significantly improved progression-free and overall survival in advanced melanoma patients carrying BRAF mutations. Nevertheless, despite these improvements, resistance still develops within the first year of therapy in around 50% of patients, which is a significant problem in managing BRAF-mutated advanced melanoma. Understanding these mechanisms is one of the mainstreams of the research on BRAFi/MEKi acquired resistance. Both genetic and epigenetic mechanisms have been described. Moreover, in recent years, oxidative stress has emerged as another major force involved in all the phases of melanoma development, from initiation to progression until the onsets of the metastatic phenotype and chemoresistance, and has thus become a target for therapy. In the present review, we discuss the current knowledge on oxidative stress and its signaling in melanoma, as well as the oxidative stress-related mechanisms in the acquired resistance to targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There is overwhelming evidence that oxidative stress plays a central role in the different stages of melanomagenesis [ 72 , 73 ].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Yang, P., Sun, D., & Jiang, F. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15149775533331 · Cited by 36
RetractedGao, W., Ge, S., & Sun, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.114 · Cited by 33
RetractedRETRACTED: Ailanthone Induces Cell Cycle Arrest and Apoptosis in Melanoma B16 and A375 Cells
Liu, W., Liu, X., Pan, Z., Wang, D., Li, M., Chen, X., Zhou, L., Xu, M., Li, D., & Zheng, Q. (2019) · Biomolecules · doi:10.3390/biom9070275 · Cited by 28
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“Globally, in 2020, new melanoma cases occurred in 324,635 people and resulted in 57,043 deaths [1].”
BackgroundMutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · cited 6×
“In particular, in BRAF V600E mutant melanoma, the MAPK activated pathway leads to hyperphosphorylation of FAM129B, which in turn can compete with Nrf2 for the binding to Keap1; in the absence of its inhibitor Keap1, Nrf2 protein is more stable; thus, its level can increase [155].”
BackgroundInfluentialImproved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · cited 2×
“This process is known as lipid peroxidation (LPO) and induces the formation of lipid radicals and other reactive intermediates (lipid radical L•, lipid peroxy radical L-OO•, lipid hydroperoxide L-OOH), as well as several highly reactive aldehydes, including 4-hydroxynonenal (HNE) and malondialdehyde (MDA), further amp…”
BackgroundNitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/360438 · Cited by 6,349 · cited 12×
“GSTs are a family of detoxification enzymes able to conjugate reduced GSH to a wide number of exogenous and endogenous electrophilic and hydrophobic substrates, participating in tumorigenic processes and drug resistance [169].”
BackgroundInfluentialRole of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,566 · cited 1×
“Oxidative stress describes an imbalance between the production of ROS/RNS in tissues and the ability, from the biological systems, to detoxify these highly reactive species or to repair the resulting damage [37,38].”
BackgroundGinestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aao3290 · Cited by 3,107
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · cited 2×
“Another important source of ROS in the skin is melanin synthesis, which involves oxidative reactions, with the production of superoxide anion and hydrogen peroxide (H2O2) at various steps of the synthetic melanin pathway [88].”
BackgroundCombined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810 · cited 2×
“Indeed, when comparing BRAFi/MEKi combination therapy with BRAFi alone, increases in progression-free survival (PFS) and the overall survival (OS) have been proven [12].”
BackgroundThe role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,806 · cited 2×
“However, this adaptative process seems to elicit the rise of more resistant cell subclones [59,60].”
BackgroundImproved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Robert, C., Karaszewska, B., Schachter, J., Rutkowski, P., Mackiewicz, A., Stroiakovski, D., Lichinitser, M., Dummer, R., Grange, F., Mortier, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412690 · Cited by 2,701
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610 · cited 1×
“Activating mutations in BRAF are the most frequent genetic alterations, present in approximately 50% of all melanoma cases [7], and more than 90% of those have an activating valine–glutamic acid substitution in codon 600 of the BRAF (V600E) [8].”
BackgroundWallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404 · cited 1×
“In cancer cells, the major source of ROS/RNS has been attributed to the dysfunction of mitochondrial respiratory chain enzymes [99]; however, in melanoma, other enzymes seem to play a major role in ROS production: the NOX family, nitric oxide synthases (NOSs), arachidonic acid cyclooxygenases (COXs), and lipoxygenases…”
BackgroundMelanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M.-K., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,192
ROS in cancer therapy: the bright side of the moon
Perillo, B., Di Donato, M., Pezone, A., Di Zazzo, E., Giovannelli, P., Galasso, G., Castoria, G., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0384-2 · Cited by 2,176
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068 · cited 1×
“2 months, respectively), and 9-month survival rates (81% versus 73%, respectively) [16].”
New photosensitizers for photodynamic therapy
Abrahamse, H., & Hamblin, M. R. (2016) · Biochemical Journal · doi:10.1042/bj20150942 · Cited by 2,033
ROS signalling in the biology of cancer
Moloney, J. N., & Cotter, T. G. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.05.023 · Cited by 1,970
Free Radical Lipid Peroxidation: Mechanisms and Analysis
Yin, H., Xu, L., & Porter, N. A. (2011) · Chemical Reviews · doi:10.1021/cr200084z · Cited by 1,937
Geller, L. T., Barzily-Rokni, M., Danino, T., Jonas, O. H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z. A., Shee, K., et al. (2017) · Science · doi:10.1126/science.aah5043 · Cited by 1,817
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672 · cited 2×
“One of the main proteins involved in regulating antioxidant response is the transcription factor Nrf2 (NF-E2-related factor 2), which has been considered the master regulator of cytoprotective and antioxidant genes [63,64].”
BackgroundMitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Sabharwal, S. S., & Schumacker, P. T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3803 · Cited by 1,622 · cited 1×
“In terms of internal mechanisms, ROS production is enhanced in cancer cells as a result of the activation of several well-known oncogenes, loss of tumor suppressors [84,85], tumor hypoxia [84,86], altered integrin signaling [87], and reprogrammed metabolism [84,88].”
BackgroundRole of ROS and RNS Sources in Physiological and Pathological Conditions
Di Meo, S., Reed, T. T., Venditti, P., & Victor, V. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1245049 · Cited by 1,614 · cited 1×
“ROS/RNS, which are constantly produced in living organisms, include free radicals (superoxide anion O2; hydroxyl radical •OH; nitric oxide NO•; nitrogen dioxide NO2) and nonradicals, such as singlet oxygen (1O2), peroxides (hydrogen peroxide H2O2; peroxynitrite ONOO−), and hypochlorous acid (HOCl) [39,40].”
BackgroundGur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Schadendorf, D., van Akkooi, A. C. J., Berking, C., Griewank, K. G., Gutzmer, R., Hauschild, A., Stang, A., Roesch, A., & Ugurel, S. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31559-9 · Cited by 1,488
Free-radical chemistry of cigarette smoke and its toxicological implications.
Church, D. F., & Pryor, W. A. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.8564111 · Cited by 1,441 · cited 1×
“Cigarette smoke and ultraviolet (UV) radiation are certainly among the primary external causes of ROS increasing [82,83].”
BackgroundLong, G. V., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Grob, J.-J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60898-4 · Cited by 1,399 · cited 1×
“7 months, respectively, were the median OS [14].”
BackgroundOxidative stress inhibits distant metastasis by human melanoma cells
Piskounova, E., Agathocleous, M., Murphy, M. M., Hu, Z., Huddlestun, S. E., Zhao, Z., Leitch, A. M., Johnson, T. M., DeBerardinis, R. J., & Morrison, S. J. (2015) · Nature · doi:10.1038/nature15726 · Cited by 1,269
Antioxidant responses and cellular adjustments to oxidative stress
Espinosa-Diez, C., Miguel, V., Mennerich, D., Kietzmann, T., Sánchez-Pérez, P., Cadenas, S., & Lamas, S. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.008 · Cited by 1,086 · cited 2×
“However, this adaptative process seems to elicit the rise of more resistant cell subclones [59,60].”
BackgroundBenedetti, A., Comporti, M., & Esterbauer, H. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90209-x · Cited by 1,085 · cited 22×
“Indeed, at micromolar concentrations similar to those found in human plasma and tissues, HNE has shown antiproliferative, Antioxidants 2021, 10, 1942 14 of 30 proapoptotic, antiangiogenic, and prodifferentiative actions in a wide variety of tumor cells in vitro by modulating the expression of critical genes for cancer…”
BackgroundInfluentialCyclophosphamide and cancer: golden anniversary
Emadi, A., Jones, R. J., & Brodsky, R. A. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.146 · Cited by 1,050
Dummer, R., Ascierto, P. A., Gogas, H. J., Arance, A., Mandala, M., Liszkay, G., Garbe, C., Schadendorf, D., Krajsova, I., Gutzmer, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30142-6 · Cited by 1,037 · cited 1×
“9 months [17]; moreover, the median PFS was 14.”
BackgroundDissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Wagle, N., Emery, C., Berger, M. F., Davis, M. J., Sawyer, A., Pochanard, P., Kehoe, S. M., Johannessen, C. M., MacConaill, L. E., Hahn, W. C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.2312 · Cited by 1,005 · cited 1×
“BRAF splice site variants, and activating mutations of NRAS and MEK1/2 have been described [19].”
BackgroundReactive Oxygen Species: Drivers of Physiological and Pathological Processes
Checa, J., & Aran, J. M. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s275595 · Cited by 984 · cited 1×
“During inflammation, ROS can be overproduced since they are highly toxic to pathogens [43].”
BackgroundDirect and indirect effects of UV radiation on DNA and its components
Ravanat, J.-L., Douki, T., & Cadet, J. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00206-8 · Cited by 980
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Snezhkina, A. V., Kudryavtseva, A. V., Kardymon, O. L., Savvateeva, M. V., Melnikova, N. V., Krasnov, G. S., & Dmitriev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6175804 · Cited by 934
Shain, A. H., & Bastian, B. C. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.37 · Cited by 896 · cited 1×
“Thus, higher levels of pheomelanin can indirectly contribute to mutagenesis through enhanced ROS production [96].”
BackgroundReactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893 · cited 1×
“For instance, scientists have highlighted some paradoxes relating to the two faces of ROS, which are able to both promote and suppress cancer [74].”
BackgroundOxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy
Barrera, G. (2012) · ISRN Oncology · doi:10.5402/2012/137289 · Cited by 820 · cited 1×
“These secondary lipid peroxidation products are mainly composed of reactive aldehydes, such as MDA, HNE, hexanal, and acrolein, and have been extensively studied for their surprising and sometimes unexpected biological activities [45,51,61,66,209].”
BackgroundSelf-citationThe role of cellular reactive oxygen species in cancer chemotherapy
Yang, H., Villani, R. M., Wang, H., Simpson, M. J., Roberts, M. S., Tang, M., & Liang, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0909-x · Cited by 794 · cited 1×
“In terms of internal mechanisms, ROS production is enhanced in cancer cells as a result of the activation of several well-known oncogenes, loss of tumor suppressors [84,85], tumor hypoxia [84,86], altered integrin signaling [87], and reprogrammed metabolism [84,88].”
BackgroundNADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
Vermot, A., Petit-Härtlein, I., Smith, S. M. E., & Fieschi, F. (2021) · Antioxidants · doi:10.3390/antiox10060890 · Cited by 766 · cited 1×
“The first identified member was NOX2, present in the phagocytic vacuole of “professional” phagocytes; later, six additional members were found (NOX1, NOX3, NOX4, NOX5, DUOX1, DUOX2) [100].”
BackgroundChemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness
Conklin, K. A. (2004) · Integrative Cancer Therapies · doi:10.1177/1534735404270335 · Cited by 752
Mouret, S., Baudouin, C., Charveron, M., Favier, A., Cadet, J., & Douki, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604213103 · Cited by 684 · cited 1×
“Cigarette smoke and ultraviolet (UV) radiation are certainly among the primary external causes of ROS increasing [82,83].”
BackgroundKwak, M.-K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., & Kensler, T. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211898200 · Cited by 660
LAU, A., VILLENEUVE, N., SUN, Z., WONG, P., & ZHANG, D. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.003 · Cited by 645
Antioxidants can increase melanoma metastasis in mice
Le Gal, K., Ibrahim, M. X., Wiel, C., Sayin, V. I., Akula, M. K., Karlsson, C., Dalin, M. G., Akyürek, L. M., Lindahl, P., Nilsson, J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3740 · Cited by 632
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
Hugo, W., Shi, H., Sun, L., Piva, M., Song, C., Kong, X., Moriceau, G., Hong, A., Dahlman, K. B., Johnson, D. B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.061 · Cited by 600 · cited 1×
“DNA methylation pattern at individual CpG sites [29], post-translational modifications of histones, and noncoding RNA deregulation have been demonstrated to be involved [30].”
BackgroundBasit, F., van Oppen, L. M., Schöckel, L., Bossenbroek, H. M., van Emst-de Vries, S. E., Hermeling, J. C., Grefte, S., Kopitz, C., Heroult, M., HGM Willems, P., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.133 · Cited by 565
Oxidative stress: damage to intact cells and organs
Sies, H., & Cadenas, E. (1985) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1985.0168 · Cited by 551 · cited 1×
“Oxidative stress describes an imbalance between the production of ROS/RNS in tissues and the ability, from the biological systems, to detoxify these highly reactive species or to repair the resulting damage [37,38].”
BackgroundBRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
Rizos, H., Menzies, A. M., Pupo, G. M., Carlino, M. S., Fung, C., Hyman, J., Haydu, L. E., Mijatov, B., Becker, T. M., Boyd, S. C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3122 · Cited by 547 · cited 1×
“In melanoma patients resistant to targeted therapy, mutations leading to the reactivation of the MAPK pathway are the most representative [18].”
BackgroundA Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
Konieczkowski, D. J., Johannessen, C. M., Abudayyeh, O., Kim, J. W., Cooper, Z. A., Piris, A., Frederick, D. T., Barzily-Rokni, M., Straussman, R., Haq, R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0424 · Cited by 535 · cited 1×
“On the contrary, other studies have demonstrated that during the acquisition of the resistance to targeted therapies, a population of melanoma cells exhibited low MITF expression [36].”
ResultAldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
Marcato, P., Dean, C. A., Giacomantonio, C. A., & Lee, P. W. K. (2011) · Cell Cycle · doi:10.4161/cc.10.9.15486 · Cited by 516
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
Weinberg, F., Ramnath, N., & Nagrath, D. (2019) · Cancers · doi:10.3390/cancers11081191 · Cited by 502
Marcato, P., Dean, C. A., Pan, D., Araslanova, R., Gillis, M., Joshi, M., Helyer, L., Pan, L., Leidal, A., Gujar, S., et al. (2011) · Stem Cells · doi:10.1002/stem.563 · Cited by 483
Church, S. L., Grant, J. W., Ridnour, L. A., Oberley, L. W., Swanson, P. E., Meltzer, P. S., & Trent, J. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.3113 · Cited by 473
Nrf2 in cancers: A double‐edged sword
Wu, S., Lu, H., & Bai, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2101 · Cited by 465 · cited 1×
“Similarly, Nrf2 and its antioxidant target genes are regarded as double-edged swords, with their anticancer and protumoral activities, depending on the stages of malignant transformation [75].”
BackgroundPathological aspects of lipid peroxidation
Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498478 · Cited by 449
Reactive oxygen species as essential mediators of cell adhesion
Chiarugi, P., Pani, G., Giannoni, E., Taddei, L., Colavitti, R., Raugei, G., Symons, M., Borrello, S., Galeotti, T., & Ramponi, G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211118 · Cited by 444 · cited 1×
“In terms of internal mechanisms, ROS production is enhanced in cancer cells as a result of the activation of several well-known oncogenes, loss of tumor suppressors [84,85], tumor hypoxia [84,86], altered integrin signaling [87], and reprogrammed metabolism [84,88].”
BackgroundRho-family GTPases in cadherin-mediated cell — cell adhesion
Fukata, M., & Kaibuchi, K. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35103068 · Cited by 438
The global burden of melanoma: results from the Global Burden of Disease Study 2015
Karimkhani, C., Green, A. C., Nijsten, T., Weinstock, M. A., Dellavalle, R. P., Naghavi, M., & Fitzmaurice, C. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15510 · Cited by 436
Melanocytes as Instigators and Victims of Oxidative Stress
Denat, L., Kadekaro, A. L., Marrot, L., Leachman, S. A., & Abdel-Malek, Z. A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.65 · Cited by 416 · cited 2×
“Moreover, melanin has a two-faced role in determining oxidative stress levels: on the one hand, it absorbs UV radiation, thus protecting skin cells from oxidative damage; on the other hand, it shows pro-oxidant activities [94].”
BackgroundCheng, L., Lopez-Beltran, A., Massari, F., MacLennan, G. T., & Montironi, R. (2018) · Modern Pathology · doi:10.1038/modpathol.2017.104 · Cited by 407 · cited 1×
“Furthermore, other, less frequent missense mutations of this codon have been described in melanoma, such as V600K, V600R, and V600D [9].”
BackgroundHeme Oxygenase-1 in Tumors: Is It a False Friend?
Jozkowicz, A., Was, H., & Dulak, J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1659 · Cited by 382
Girotti, M. R., Pedersen, M., Sanchez-Laorden, B., Viros, A., Turajlic, S., Niculescu-Duvaz, D., Zambon, A., Sinclair, J., Hayes, A., Gore, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0386 · Cited by 382
Nanotechnology-based approaches in anticancer research
Kamal, M. A., Jabir NR, N., Tabrez, Ashraf, Shakil, & Damanhouri (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33838 · Cited by 363
Oxidatively Generated Damage to Cellular DNA by UVB and UVA Radiation ,
Cadet, J., Douki, T., & Ravanat, J. (2015) · Photochemistry and Photobiology · doi:10.1111/php.12368 · Cited by 355 · cited 1×
“UV irradiation, a major contributor to skin cancer, can directly damage DNA via forming a large amount of cyclobutane pyrimidine dimers (CPDs), pyrimidine (6-4) pyrimidone adducts [79]; moreover, UV induces the skin to produce, through photosensitizer molecules, high levels of ROS (singlet oxygen and hydroxyl radicals…”
BackgroundHirose, K., Longo, D. L., Oppenheim, J. J., & Matsushima, K. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.2.8440412 · Cited by 340
Short Overview of ROS as Cell Function Regulators and Their Implications in Therapy Concepts
Milkovic, L., Cipak Gasparovic, A., Cindric, M., Mouthuy, P.-A., & Zarkovic, N. (2019) · Cells · doi:10.3390/cells8080793 · Cited by 330 · cited 1×
“ROS can act as intracellular signaling molecules, participating in the homeostatic adaptation of cells to external stimuli [41,42].”
BackgroundAn Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
Wang, L., Leite de Oliveira, R., Huijberts, S., Bosdriesz, E., Pencheva, N., Brunen, D., Bosma, A., Song, J.-Y., Zevenhoven, J., Los-de Vries, G. T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.012 · Cited by 327
Barrera, G., Pizzimenti, S., Daga, M., Dianzani, C., Arcaro, A., Cetrangolo, G. P., Giordano, G., Cucci, M. A., Graf, M., & Gentile, F. (2018) · Antioxidants · doi:10.3390/antiox7080102 · Cited by 326
Self-citationRecovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
Paraiso, K. H. T., Fedorenko, I. V., Cantini, L. P., Munko, A. C., Hall, M., Sondak, V. K., Messina, J. L., Flaherty, K. T., & Smalley, K. S. M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605714 · Cited by 314
Biochemical basis and metabolic interplay of redox regulation
Zhang, L., Wang, X., Cueto, R., Effi, C., Zhang, Y., Tan, H., Qin, X., Ji, Y., Yang, X., & Wang, H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101284 · Cited by 308 · cited 2×
“ROS can be generated by nonenzymatic processes, such as the Fenton/Haber–Weiss reaction, and enzymatic reactions, which include the mitochondrial electron transport chain, nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs), cyclooxygenases, or xanthine oxidases [40].”
BackgroundOxidative stress in malignant melanoma and non-melanoma skin cancer
Sander, C. S., Hamm, F., Elsner, P., & Thiele, J. J. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05303.x · Cited by 300
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
Vassalli, G. (2019) · Stem Cells International · doi:10.1155/2019/3904645 · Cited by 300
Aldehyde dehydrogenases and cell proliferation
Muzio, G., Maggiora, M., Paiuzzi, E., Oraldi, M., & Canuto, R. A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.033 · Cited by 297
Self-citationThe Nrf2/HO‐1 Axis in Cancer Cell Growth and Chemoresistance
Furfaro, A. L., Traverso, N., Domenicotti, C., Piras, S., Moretta, L., Marinari, U. M., Pronzato, M. A., & Nitti, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1958174 · Cited by 295
Phospholipid Hydroperoxides Are Substrates for Non-selenium Glutathione Peroxidase
Fisher, A. B., Dodia, C., Manevich, Y., Chen, J.-W., & Feinstein, S. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21326 · Cited by 295
ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications
Moldogazieva, N. T., Mokhosoev, I. M., Feldman, N. B., & Lutsenko, S. V. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1457217 · Cited by 288
Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease
Li, H., & Förstermann, U. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.01.006 · Cited by 285
ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
Luo, Y., Dallaglio, K., Chen, Y., Robinson, W. A., Robinson, S. E., McCarter, M. D., Wang, J., Gonzalez, R., Thompson, D. C., Norris, D. A., et al. (2012) · Stem Cells · doi:10.1002/stem.1193 · Cited by 281
Tarver, T. (2012) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2012.701177 · Cited by 278
Habib, E., Linher-Melville, K., Lin, H.-X., & Singh, G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.03.003 · Cited by 271 · cited 12×
“GSTs are a family of detoxification enzymes able to conjugate reduced GSH to a wide number of exogenous and endogenous electrophilic and hydrophobic substrates, participating in tumorigenic processes and drug resistance [169].”
BackgroundInfluentialCutaneous Melanoma: Etiology and Therapy
(2017) · Codon Publications eBooks · doi:10.15586/codon.cutaneousmelanoma.2017 · Cited by 271
Overexpression of Akt converts radial growth melanoma to vertical growth melanoma
Govindarajan, B., Sligh, J. E., Vincent, B. J., Li, M., Canter, J. A., Nickoloff, B. J., Rodenburg, R. J., Smeitink, J. A., Oberley, L., Zhang, Y., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30102 · Cited by 270
Le Noci, V., Guglielmetti, S., Arioli, S., Camisaschi, C., Bianchi, F., Sommariva, M., Storti, C., Triulzi, T., Castelli, C., Balsari, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.090 · Cited by 270
Grob, J. J., Amonkar, M. M., Karaszewska, B., Schachter, J., Dummer, R., Mackiewicz, A., Stroyakovskiy, D., Drucis, K., Grange, F., Chiarion-Sileni, V., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00087-x · Cited by 269
Kadekaro, A. L., Kavanagh, R., Kanto, H., Terzieva, S., Hauser, J., Kobayashi, N., Schwemberger, S., Cornelius, J., Babcock, G., Shertzer, H. G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4535 · Cited by 259 · cited 1×
“Furthermore, the human melanocortin 1 receptor gene (MC1R) wild type signaling, which is responsible for black eumelanin production [97], also promoted DNA repair and ROS scavenging [98]; loss-of-function variants of MC1R associated to pheomelanin production [97] elicited enhanced ROS production and impairment of DNA…”
BackgroundMelanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3
Abel, E. V., Basile, K. J., Kugel, C. H., Witkiewicz, A. K., Le, K., Amaravadi, R. K., Karakousis, G. C., Xu, X., Xu, W., Schuchter, L. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65780 · Cited by 244
Inhibition of cancer antioxidant defense by natural compounds
Sznarkowska, A., Kostecka, A., Meller, K., & Bielawski, K. P. (2017) · Oncotarget · doi:10.18632/oncotarget.13723 · Cited by 241
4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases
Shoeb, M., Ansari, N., Srivastava, S., & Ramana, K. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990181 · Cited by 230
Glutathione S-Transferases in Cancer
Singh, R. R., & Reindl, K. M. (2021) · Antioxidants · doi:10.3390/antiox10050701 · Cited by 230
Overexpression of peroxiredoxin in human breast cancer.
Noh, D.-Y., Ahn, S. J., Lee, R., Kim, S., Park, I. A., & Chae, H. Z. (2001) · PubMed · Cited by 221
Phenformin enhances the therapeutic benefit of BRAF V600E inhibition in melanoma
Yuan, P., Ito, K., Perez-Lorenzo, R., Del Guzzo, C., Lee, J. H., Shen, C.-H., Bosenberg, M. W., McMahon, M., Cantley, L. C., & Zheng, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317577110 · Cited by 218
MC 1R, Eumelanin and Pheomelanin: Their Role in Determining the Susceptibility to Skin Cancer
Nasti, T. H., & Timares, L. (2015) · Photochemistry and Photobiology · doi:10.1111/php.12335 · Cited by 217
Xing, F., Persaud, Y., Pratilas, C. A., Taylor, B. S., Janakiraman, M., She, Q.-B., Gallardo, H., Liu, C., Merghoub, T., Hefter, B., et al. (2012) · Oncogene · doi:10.1038/onc.2011.250 · Cited by 207 · cited 1×
“Several other non-MAPK pathway dysregulations have been described in BRAFi/MEKi resistance, such as the copy number variations of cyclin D1 and cyclin-dependent kinase inhibitor p16INK4A and the inactivation of retinoblastoma (Rb) protein [27,28].”
BackgroundDNA damage by lipid peroxidation products: Implications in cancer, inflammation and autoimmunity
Gentile, F., Arcaro, A., Pizzimenti, S., Daga, M., Cetrangolo, G. P., Dianzani, C., Lepore, A., Graf, M., Ames, P. R. J., & Barrera, G. (2017) · AIMS Genetics · doi:10.3934/genet.2017.2.103 · Cited by 205 · cited 1×
“HNE–DNA adducts could contribute to the mutagenic and carcinogenic effects associated with oxidative stress-induced LPO; not only are HNE–protein adducts markers of LPO, but the covalent modifications of proteins can profoundly modify their biological activity, contributing to the complex biological consequences obser…”
BackgroundSelf-citationManganese superoxide dismutase regulation and cancer
Dhar, S. K., & St. Clair, D. K. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.009 · Cited by 196
Extracellular superoxide dismutase and its role in cancer
Griess, B., Tom, E., Domann, F., & Teoh-Fitzgerald, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.013 · Cited by 195
Valencia, A., & Kochevar, I. E. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700960 · Cited by 194 · cited 3×
“ROS can be generated by nonenzymatic processes, such as the Fenton/Haber–Weiss reaction, and enzymatic reactions, which include the mitochondrial electron transport chain, nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs), cyclooxygenases, or xanthine oxidases [40].”
BackgroundOverexpression of Heme Oxygenase-1 in Murine Melanoma
Was, H., Cichon, T., Smolarczyk, R., Rudnicka, D., Stopa, M., Chevalier, C., Leger, J. J., Lackowska, B., Grochot, A., Bojkowska, K., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051365 · Cited by 192
Ekmekçioglu, S., Ellerhorst, J. A., Smid, C. M., Prieto, V. G., Munsell, M. F., Buzaid, A. C., & Grimm, E. A. (2000) · PubMed · Cited by 192
Bioactive Lipoxygenase Metabolites Stimulation of NADPH Oxidases and Reactive Oxygen Species
Cho, K.-J., Seo, J.-M., & Kim, J.-H. (2011) · Molecules and Cells · doi:10.1007/s10059-011-1021-7 · Cited by 189
Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth
Li, Y., Elmén, L., Segota, I., Xian, Y., Tinoco, R., Feng, Y., Fujita, Y., Segura Muñoz, R. R., Schmaltz, R., Bradley, L. M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.035 · Cited by 189
Hall, A., Meyle, K. D., Lange, M. K., Klima, M., Sanderhoff, M., Dahl, C., Abildgaard, C., Thorup, K., Moghimi, S. M., Jensen, P. B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.965 · Cited by 188
Yamaura, M., Mitsushita, J., Furuta, S., Kiniwa, Y., Ashida, A., Goto, Y., Shang, W. H., Kubodera, M., Kato, M., Takata, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3745 · Cited by 187
Drug Delivery Nanoparticles in Skin Cancers
Dianzani, C., Zara, G. P., Maina, G., Pettazzoni, P., Pizzimenti, S., Rossi, F., Gigliotti, C. L., Ciamporcero, E. S., Daga, M., & Barrera, G. (2014) · BioMed Research International · doi:10.1155/2014/895986 · Cited by 184
Self-citationZhang, H. J., Zhao, W., Venkataraman, S., Robbins, M. E. C., Buettner, G. R., Kregel, K. C., & Oberley, L. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109801200 · Cited by 180
Resistance to Selective BRAF Inhibition Can Be Mediated by Modest Upstream Pathway Activation
Su, F., Bradley, W. D., Wang, Q., Yang, H., Xu, L., Higgins, B., Kolinsky, K., Packman, K., Kim, M. J., Trunzer, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1875 · Cited by 179 · cited 1×
“8 months, quite often caused by a reactivation of the MAPK pathway [11].”
BackgroundCorazao-Rozas, P., Guerreschi, P., Jendoubi, M., André, F., Jonneaux, A., Scalbert, C., Garçon, G., Malet-Martino, M., Balayssac, S., Rocchi, S., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1420 · Cited by 178
An NAD(P)H oxidase regulates growth and transcription in melanoma cells
Brar, S. S., Kennedy, T. P., Sturrock, A. B., Huecksteadt, T. P., Quinn, M. T., Whorton, A. R., & Hoidal, J. R. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00496.2001 · Cited by 178 · cited 1×
“Interestingly, early studies suggested that NOXs contribute to melanoma cell proliferation [101].”
BackgroundIdentification of the functional role of peroxiredoxin 6 in the progression of breast cancer
Chang, X.-Z., Li, D.-Q., Hou, Y.-F., Wu, J., Lu, J.-S., Di, G.-H., Jin, W., Ou, Z.-L., Shen, Z.-Z., & Shao, Z.-M. (2007) · Breast Cancer Research · doi:10.1186/bcr1789 · Cited by 177
Syed, D. N., Afaq, F., Maddodi, N., Johnson, J. J., Sarfaraz, S., Ahmad, A., Setaluri, V., & Mukhtar, H. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.6 · Cited by 171
Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
Proietti, I., Skroza, N., Bernardini, N., Tolino, E., Balduzzi, V., Marchesiello, A., Michelini, S., Volpe, S., Mambrin, A., Mangino, G., et al. (2020) · Cancers · doi:10.3390/cancers12102801 · Cited by 168 · cited 1×
“These epigenetic mechanisms profoundly affect the expression of critical genes involved in favoring the growth and progression of melanoma, such as a set of transcriptional “master regulators” [31].”
BackgroundPathophysiological relevance of aldehydic protein modifications
Žarković, N., Gašparović, A. Č., Jaganjac, M., Borović, S., & Žarković, K. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.02.004 · Cited by 165
Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma
Lim, S. Y., Menzies, A. M., & Rizos, H. (2017) · Cancer · doi:10.1002/cncr.30435 · Cited by 162 · cited 1×
“In addition to reactivation of the MAPK pathway, in around 20% of melanoma patients developing resistance to targeted therapy, there is increased signaling in the phosphatidylinositol 3-kinase (PI3K) and protein kinase B (AKT) pathway [20].”
BackgroundThe NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
Jaganjac, M., Milkovic, L., Sunjic, S. B., & Zarkovic, N. (2020) · Antioxidants · doi:10.3390/antiox9111151 · Cited by 162
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth
Schöckel, L., Glasauer, A., Basit, F., Bitschar, K., Truong, H., Erdmann, G., Algire, C., Hägebarth, A., Willems, P. H., Kopitz, C., et al. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0138-0 · Cited by 161
Mayola, E., Gallerne, C., Esposti, D. D., Martel, C., Pervaiz, S., Larue, L., Debuire, B., Lemoine, A., Brenner, C., & Lemaire, C. (2011) · Apoptosis · doi:10.1007/s10495-011-0625-x · Cited by 161
Lipid peroxidation: control of cell proliferation, cell differentiation and cell death
Barrera, G., Pizzimenti, S., & Dianzani, M. U. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.012 · Cited by 160 · cited 2×
“Dianzani gave a fundamental contribution to the comprehension of the role played by HNE and other aldehydic products derived from lipid peroxidation in human diseases [50,51].”
BackgroundSelf-citationPhotodynamic Therapy for Metastatic Melanoma Treatment: A Review
Naidoo, C., Kruger, C. A., & Abrahamse, H. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818791795 · Cited by 160
The gut microbiome: what the oncologist ought to know
Lee, K. A., Luong, M., Shaw, H. M., Nathan, P., Bataille, V. A., & Spector, T. D. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01467-x · Cited by 159
Reactive oxygen species in melanoma and its therapeutic implications
Wittgen, H. G. M., & van Kempen, L. C. L. T. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282f1d312 · Cited by 156 · cited 1×
“Two important tissue characteristics may explain this further increase: the natural exposure to UV radiation and the presence of melanin [90].”
BackgroundEndothelial Nitric Oxide Synthase Mediates Lymphangiogenesis and Lymphatic Metastasis
Lahdenranta, J., Hagendoorn, J., Padera, T. P., Hoshida, T., Nelson, G. M., Kashiwagi, S., Jain, R. K., & Fukumura, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4051 · Cited by 155
Nitric Oxide: The Forgotten Child of Tumor Metabolism
Rizi, B. S., Achreja, A., & Nagrath, D. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.07.005 · Cited by 149 · cited 14×
“Consequences of ROS/RNS Increase Enhanced ROS production triggers the occurrence and development of melanoma through genotoxic and nongenotoxic pathways.”
BackgroundInfluentialMiyano, K., Ueno, N., Takeya, R., & Sumimoto, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513665200 · Cited by 148 · cited 3×
“Moreover, NOX enzymes can be activated by arachidonic acid metabolites from both the COX and LOX pathways, as well as from the activated N-RAS, AKT, and RAC1 oncogenic pathways.”
BackgroundSOD1, an unexpected novel target for cancer therapy.
Papa, L., Manfredi, G., & Germain, D. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.4 · Cited by 147
Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases
Barrera, G., Pizzimenti, S., Ciamporcero, E. S., Daga, M., Ullio, C., Arcaro, A., Cetrangolo, G. P., Ferretti, C., Dianzani, C., Lepore, A., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6166 · Cited by 146 · cited 1×
“HNE–DNA adducts could contribute to the mutagenic and carcinogenic effects associated with oxidative stress-induced LPO; not only are HNE–protein adducts markers of LPO, but the covalent modifications of proteins can profoundly modify their biological activity, contributing to the complex biological consequences obser…”
BackgroundSelf-citationAzimi, I., Petersen, R. M., Thompson, E. W., Roberts‐Thomson, S. J., & Monteith, G. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-15474-7 · Cited by 146 · cited 1×
“In terms of internal mechanisms, ROS production is enhanced in cancer cells as a result of the activation of several well-known oncogenes, loss of tumor suppressors [84,85], tumor hypoxia [84,86], altered integrin signaling [87], and reprogrammed metabolism [84,88].”
BackgroundRedox-Mediated Mechanism of Chemoresistance in Cancer Cells
Kim, E.-K., Jang, M., Song, M.-J., Kim, D., Kim, Y., & Jang, H. H. (2019) · Antioxidants · doi:10.3390/antiox8100471 · Cited by 145
Ramsdale, R., Jorissen, R. N., Li, F. Z., Al-Obaidi, S., Ward, T., Sheppard, K. E., Bukczynska, P. E., Young, R. J., Boyle, S. E., Shackleton, M., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aab1111 · Cited by 143 · cited 1×
“The inhibition of this transcriptional master regulator together with BRAFi [33] elicited cell death decreased a population of melanoma cells with a mesenchymal-like phenotype, which represents an early adaptive state adopted by some melanoma cells in response to BRAFi [33–35].”
BackgroundRoles and Functions of ROS and RNS in Cellular Physiology and Pathology
Žarković, N. (2020) · Cells · doi:10.3390/cells9030767 · Cited by 143
A catalogue of somatic NRF2 gain-of-function mutations in cancer
Kerins, M. J., & Ooi, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-31281-0 · Cited by 140
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
Avagliano, A., Fiume, G., Pelagalli, A., Sanità, G., Ruocco, M. R., Montagnani, S., & Arcucci, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00722 · Cited by 138
Saleem, M., Maddodi, N., Zaid, M. I. A., Khan, N., Hafeez, B. B., Asim, M., Suh, Y. K., Yun, J., Setaluri, V., & Mukhtar, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4413 · Cited by 137
The Double-Faced Role of Nitric Oxide and Reactive Oxygen Species in Solid Tumors
Mijatović, S., Savic-Radojevic, A. R., Pljesa-Ercegovac, M. S., Simic, T. P., Nicoletti, F., & Maksimović‐Ivanić, D. (2020) · Antioxidants · doi:10.3390/antiox9050374 · Cited by 137
Sikora, A. G., Gelbard, A. H., Davies, M. A., Sano, D., Ekmekçioglu, S., Kwon, J., Hailemichael, Y., Jayaraman, P., Myers, J. N., Grimm, E. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3123 · Cited by 135
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
Rocha, C. R. R., Kajitani, G. S., Quinet, A., Fortunato, R. S., & Menck, C. F. M. (2016) · Oncotarget · doi:10.18632/oncotarget.10129 · Cited by 135
4-Hydroxynonenal from pathology to physiology
Dianzani, M. U. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00021-9 · Cited by 134 · cited 1×
“Dianzani gave a fundamental contribution to the comprehension of the role played by HNE and other aldehydic products derived from lipid peroxidation in human diseases [50,51].”
BackgroundThe Potential of Lactobacillus spp. for Modulating Oxidative Stress in the Gastrointestinal Tract
Kong, Y., Olejar, K. J., On, S. L. W., & Chelikani, V. (2020) · Antioxidants · doi:10.3390/antiox9070610 · Cited by 133
ANTIOXIDANT STATUS AND LIPID PEROXIDATION IN COLORECTAL CANCER
Skrzydlewska, E., Stankiewicz, A., SULKOWSKA, M., Sulkowski, S., & Kasacka, I. (2001) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390152543690 · Cited by 127
Updates of reactive oxygen species in melanoma etiology and progression
Liu, F., Dellinger, R. W., & Meyskens, F. L. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.007 · Cited by 127 · cited 6×
“In melanomas, besides NOX, other enzymes can also contribute significantly to oxidative stress increase, such as the nitric oxide synthase (NOS) family, which can synthesize RNS such as NO [76,111].”
BackgroundResultInfluentialAberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes
Meyskens, F. L., McNulty, S. E., Buckmeier, J. A., Tohidian, N. B., Spillane, T. J., Kahlon, R. S., & Gonzalez, R. I. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00650-5 · Cited by 126 · cited 14×
“Consequences of ROS/RNS Increase Enhanced ROS production triggers the occurrence and development of melanoma through genotoxic and nongenotoxic pathways.”
BackgroundInfluentialEmerging Perspective: Role of Increased ROS and Redox Imbalance in Skin Carcinogenesis
Xian, D., Lai, R., Song, J., Xiong, X., & Zhong, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8127362 · Cited by 125 · cited 4×
“UV irradiation, a major contributor to skin cancer, can directly damage DNA via forming a large amount of cyclobutane pyrimidine dimers (CPDs), pyrimidine (6-4) pyrimidone adducts [79]; moreover, UV induces the skin to produce, through photosensitizer molecules, high levels of ROS (singlet oxygen and hydroxyl radicals…”
BackgroundInfluentialMicroRNAs in melanoma development and resistance to target therapy
Fattore, L., Costantini, S., Malpicci, D., Ruggiero, C. F., Ascierto, P. A., Croce, C. M., Mancini, R., & Ciliberto, G. (2017) · Oncotarget · doi:10.18632/oncotarget.14763 · Cited by 120
Oxidative stress and antioxidants in the pathophysiology of malignant melanoma
Obrador, E., Liu-Smith, F., Dellinger, R. W., Salvador, R., Meyskens, F. L., & Estrela, J. M. (2019) · Biological Chemistry · doi:10.1515/hsz-2018-0327 · Cited by 119
Melanoma-related changes in skin microbiome
Mrázek, J., Mekadim, C., Kučerová, P., Švejstil, R., Salmonová, H. Š., Vlasáková, J., Tarasová, R., Čížková, J., & Červinková, M. (2018) · Folia Microbiologica · doi:10.1007/s12223-018-00670-3 · Cited by 119
López-Rivera, E., Jayaraman, P., Parikh, F. S., Davies, M. A., Ekmekçioglu, S., Izadmehr, S., Milton, D. R., Chipuk, J. E., Grimm, E. A., Estrada, Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0588 · Cited by 118
MC1R: Front and Center in the Bright Side of Dark Eumelanin and DNA Repair
Swope, V. B., & ABDEL‐MALEK, Z. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092667 · Cited by 118 · cited 1×
“Furthermore, the human melanocortin 1 receptor gene (MC1R) wild type signaling, which is responsible for black eumelanin production [97], also promoted DNA repair and ROS scavenging [98]; loss-of-function variants of MC1R associated to pheomelanin production [97] elicited enhanced ROS production and impairment of DNA…”
BackgroundComporti, M., Saccocci, C., & Dianzani, U. (1965) · PubMed · Cited by 117
Liu, Y., Lv, D., Duan, J., Xu, S., Zhang, J., Yang, X., Zhang, X., Cui, Y., Bian, X., & Yu, S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-444 · Cited by 114
Heo, J., Kim, S., Hwang, K., Kang, J., & Choi, K. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3732 · Cited by 114
Metabolic flexibility in melanoma: A potential therapeutic target
Ruocco, M. R., Avagliano, A., Granato, G., Vigliar, E., Masone, S., Montagnani, S., & Arcucci, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.016 · Cited by 113
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
Panieri, E., Telkoparan‐Akillilar, P., Süzen, S., & Saso, L. (2020) · Biomolecules · doi:10.3390/biom10050791 · Cited by 108 · cited 2×
“One of the main proteins involved in regulating antioxidant response is the transcription factor Nrf2 (NF-E2-related factor 2), which has been considered the master regulator of cytoprotective and antioxidant genes [63,64].”
BackgroundAilanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
He, Y., Peng, S., Wang, J., Chen, H., Cong, X., Chen, A., Hu, M., Qin, M., Wu, H., Gao, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms13122 · Cited by 108
Barrera, G., Gentile, F., Pizzimenti, S., Canuto, R. A., Daga, M., Arcaro, A., Cetrangolo, G. P., Lepore, A., Ferretti, C., Dianzani, C., et al. (2016) · Antioxidants · doi:10.3390/antiox5010007 · Cited by 106
Self-citationControl of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
Barrera, G., Cucci, M. A., Grattarola, M., Dianzani, C., Muzio, G., & Pizzimenti, S. (2021) · Antioxidants · doi:10.3390/antiox10040510 · Cited by 103 · cited 1×
“Thus, very likely, post-translational mechanisms can account for the Nrf2 activation in melanoma [73].”
BackgroundSelf-citationLiu, F., Garcia, A., & Meyskens, F. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.119 · Cited by 102 · cited 1×
“NOX1 was found to be overexpressed in melanoma cell lines, and its ability to enhance cell invasion by matrix metalloproteinase-2 upregulation and EMT induction was demonstrated [102].”
BackgroundGorini, F., Scala, G., Cooke, M. S., Majello, B., & Amente, S. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.103027 · Cited by 102
Fallahi‐Sichani, M., Moerke, N. J., Niepel, M., Zhang, T., Gray, N. S., & Sorger, P. K. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145877 · Cited by 99
Phospholipase A2 Activity of Peroxiredoxin 6 Promotes Invasion and Metastasis of Lung Cancer Cells
Ho, J., Lee, S. B., Lee, S., Yoon, S. H., Kang, G. Y., Hwang, S., & Um, H. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0904 · Cited by 99
Prasmickaite, L., Engesæter, B. Ø., Skrbo, N., Hellenes, T., Kristian, A., Oliver, N. K., Suo, Z., & Mælandsmo, G. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010731 · Cited by 97
Quan, C., Cha, E., Lee, H.-L., Han, K. H., Lee, K. M., & Kim, W. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00659-2 · Cited by 96
Aldehyde dehydrogenase 1A1 and 1A3 isoforms – mechanism of activation and regulation in cancer
Poturnajova, M., Kozovská, Z., & Matúšková, M. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110120 · Cited by 93
Cotter, M. A., Thomas, J., Cassidy, P., Robinette, K., Jenkins, N., Florell, S. R., Leachman, S., Samlowski, W. E., & Grossman, D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1187 · Cited by 92
Khamari, R., Trinh, A., Gabert, P.-E., Corazao-Rozas, P., Riveros-Cruz, S., Balayssac, S., Malet‐Martino, M., Dekiouk, S., Curt, M. J.-C., Maboudou, P., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0340-4 · Cited by 92
Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
Fedorenko, I. V., Abel, E. V., Koomen, J. M., Fang, B., Wood, E. R., Chen, Y. A., Fisher, K. J., Iyengar, S., Dahlman, K. B., Wargo, J. A., et al. (2015) · Oncogene · doi:10.1038/onc.2015.188 · Cited by 91
PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities
Yun, H., Park, K., Lee, H. P., Lee, D. H., Jo, M., Shin, D. H., Yoon, D., Han, S., & Hong, J. T. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.001 · Cited by 90
Jessen, C., Kreß, J. K. C., Baluapuri, A., Hufnagel, A., Schmitz, W., Kneitz, S., Roth, S., Marquardt, A., Appenzeller, S., Ade, C. P., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01477-8 · Cited by 89
Karihtala, P., Kauppila, S., Puistola, U., & Jukkola‐Vuorinen, A. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.03835.x · Cited by 85
Reich, R., & Martin, G. R. (1996) · Prostaglandins · doi:10.1016/0090-6980(95)00154-9 · Cited by 85
Gebhart, V., Reiß, K., Kollau, A., Mayer, B., & Gorren, A. C. F. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.04.007 · Cited by 85
Cucci, M. A., Grattarola, M., Dianzani, C., Damia, G. L. M., Ricci, F., Roetto, A., Trotta, F., Barrera, G., & Pizzimenti, S. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.021 · Cited by 83
Self-citationNovel Delivery Systems of Polyphenols and Their Potential Health Benefits
Enaru, B., Socaci, S., Fărcaș, A. C., Socaciu, C., Danciu, C., Stănilă, A., & Diaconeasa, Z. M. (2021) · Pharmaceuticals · doi:10.3390/ph14100946 · Cited by 80
Oxidative stress in melanocyte senescence and melanoma transformation
Meierjohann, S. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.11.005 · Cited by 79 · cited 2×
“In addition, ROS have a nongenotoxic protumoral effect by modulating a number of oxidative-stress signaling pathways, as well as antioxidant pathways, such as MAPK, PI3K/protein kinase B (PKB), AKT/mammalian target of rapamycin (mTOR), Nrf2, and nuclear factor-κB (NF-κB) [77,79,126].”
BackgroundJUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma
Titz, B., Lomova, A., Le, A., Hugo, W., Kong, X., ten Hoeve, J., Friedman, M., Shi, H., Moriceau, G., Song, C., et al. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.28 · Cited by 79
The role of nitric oxide in melanoma
Yarlagadda, K., Hassani, J., Foote, I. P., & Markowitz, J. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.005 · Cited by 79
Levels of oxidative damage and lipid peroxidation in thyroid neoplasia
Young, O., Crotty, T., O'Connell, R., O'Sullivan, J. N., & Curran, A. J. (2009) · Head & Neck · doi:10.1002/hed.21247 · Cited by 77
Terra, V. A., Souza-Neto, F., Pereira, R. C., da Silva, T. N. X., Costa, A., Luiz, R. C., Cecchini, R., & Cecchini, A. L. (2012) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2012.01.003 · Cited by 77 · cited 1×
“UV irradiation, a major contributor to skin cancer, can directly damage DNA via forming a large amount of cyclobutane pyrimidine dimers (CPDs), pyrimidine (6-4) pyrimidone adducts [79]; moreover, UV induces the skin to produce, through photosensitizer molecules, high levels of ROS (singlet oxygen and hydroxyl radicals…”
BackgroundMandal, A., Bhatia, D., & Bishayee, A. (2017) · Nutrients · doi:10.3390/nu9050436 · Cited by 76
Cancer growth regulation by 4-hydroxynonenal
Gašparović, A. Č., Milković, L., Šunjić, S. B., & Žarković, N. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.030 · Cited by 75
Farhood, B., Najafi, M., Salehi, E., Goradel, N. H., Nashtaei, M. S., Khanlarkhani, N., & Mortezaee, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27594 · Cited by 73
Daga, M., Pizzimenti, S., Dianzani, C., Cucci, M. A., Cavalli, R., Grattarola, M., Ferrara, B., Scariot, V., Trotta, F., & Barrera, G. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.034 · Cited by 72
Self-citationNEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
Yang, Y., Zhou, W. H., Xia, J., Gu, Z., Wendlandt, E. B., Zhan, X., Janz, S., Tricot, G. J. K., & Zhan, F. (2014) · Oncotarget · doi:10.18632/oncotarget.2388 · Cited by 71
Yang, Z., Misner, B., Ji, H., Poulos, T. L., Silverman, R. B., Meyskens, F. L., & Yang, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4563 · Cited by 66
Pizzimenti, S., Ferracin, M., Sabbioni, S., Toaldo, C., Pettazzoni, P., Dianzani, M. U., Negrini, M., & Barrera, G. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.035 · Cited by 66
Self-citationSuwala, A. K., Koch, K., Herrera-Rios, D., Aretz, P., Uhlmann, C., Ogorek, I., Felsberg, J., Reifenberger, G., Köhrer, K., Deenen, R., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25210 · Cited by 63
Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo
Shin, S., Jeong, B., Wall, B., Li, J., Shan, N. L., Wen, Y., Goydos, J. S., & Chen, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0098-7 · Cited by 63
Preventive effect of Lactobacillus reuteri on melanoma
Luo, M., Hu, M., Xu, F., Wu, X., Dong, D., & Wang, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109929 · Cited by 62
Nanosystems for Improved Targeted Therapies in Melanoma
Beiu, C., Giurcăneanu, C., Grumezescu, A. M., Holban, A. M., Popa, L. G., & Grumezescu, A. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020318 · Cited by 62
Oberley, T. D., Toyokuni, S., & Szweda, L. I. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00117-3 · Cited by 61
Research works printed but not linked: 1
- Gracia-Sancho, J., and Salvadó, J. (2017). Oxidative Stress and Gut Microbiota. Gastrointestinal Tissue Oxidative Stress and Dietary Antioxidant, Academic Press. Chapter 8.
Cited by
Emanuelli, M., Sartini, D., Molinelli, E., Campagna, R., Pozzi, V., Salvolini, E., Simonetti, O., Campanati, A., & Offidani, A. (2022) · Antioxidants · doi:10.3390/antiox11040612 · Cited by 132
“Indeed, oxidative stress has emerged as an important player in all stages of melanoma, from genesis to progression until the development of the metastatic disease and chemoresistance, thus being a promising pathway for targeted therapy [18,19].”
BackgroundAir pollution and skin diseases: A comprehensive evaluation of the associated mechanism.
Gu, X., Li, Z., & Su, J. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116429 · Cited by 91
Oxidative Stress and Age-Related Tumors
Carlo, E. D., & Sorrentino, C. (2024) · Antioxidants · doi:10.3390/antiox13091109 · Cited by 112
“UV-induced oxidative stress is a major cause of skin cancers, including melanoma [196] and non-melanoma skin cancers [197].”
BackgroundOxidative Stress and Skin Diseases: The Role of Lipid Peroxidation
Pomi, F. L., Gammeri, L., Borgia, F., Gioacchino, M. D., & Gangemi, S. (2025) · Antioxidants · doi:10.3390/antiox14050555 · Cited by 94
“The pharmacological inhibition of GPX4 or the depletion of its cofactor, glutathione, leads to the accumulation of oxidized lipid species, ultimately triggering ferroptosis [86].”
Attri, N., Das, S., Banerjee, J., Shamsuddin, S. H., Dash, S. K., & Pramanik, A. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00153 · Cited by 67
Metadata
- Authors
- Pizzimenti, S., Ribero, S., Cucci, M. A., Grattarola, M., Monge, C., Dianzani, C., Barrera, G., & Muzio, G.
- Affiliations
- University of Turin (IT)
- Department of Clinical and Biological Science, University of Turin, 10125 Turin, Italy
- Corresponding author
- Pizzimenti, Stefania
- ORCID
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2021-12-03
- Volume
- 10
- Issue
- 12
- Pages
- 1942
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC8750393
- OpenAlex
- W4200547360
- Cited by
- 79
- References
- 295
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 14 · 2023: 21 · 2022: 13
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Dipartimenti di Eccellenza (Dipartimenti di Eccellenza 2018-2022, 2018–2022, D15D18000410001)
- Ministero dell’Istruzione, dell’Università e della Ricerca (20182022, D15D18000410001, “Dipartimenti di Eccellenza - 2018-2022”)
- Università degli Studi di Torino (2019.2252, D15D18000410001)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- melanoma, oxidative stress, acquired drug resistance, BRAF inhibitors, MEK inhibitors, BRAF mutation, MAPK signaling, epigenetic mechanisms, chemoresistance, metastasis, antioxidant signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.